Arsenale Bioyards has successfully closed a €10 million seed investment round to enhance its innovative bio-manufacturing platform, aiming to transform the industrial biotechnology landscape in Italy.

Target Company Overview

Arsenale Bioyards is a forward-thinking company reshaping the landscape of bio-manufacturing on an industrial scale. Recently, they announced the successful closure of their seed investment round, securing €10 million from CDP Venture Capital and international investors including Planet A, byFounders, and Plug and Play. This funding aims to support Arsenale's mission to transform the bio-manufacturing market, which is valued at $200 billion (source: BCG), and to create a new industrial trajectory in Italy.

Headquartered in Milan with operational sites in Pordenone, Italy, and the United States, Arsenale has developed a unique platform that bridges the gap between laboratory innovation and industrial-scale production. This enables industries such as food, chemicals, and materials to continuously develop and scale bio-based alternatives to petrochemical and animal-derived products.

Industry Overview in Italy

The bio-manufacturing sector in Italy is poised for growth as the country aims to become a leader in advanced industrial biotechnology. Italy’s industrial base is traditionally strong, supported by decades of manufacturing excellence. However, the need for sustainabl